Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

DB-1311 in Combination with BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors Pending

2025-523895-22-00 Non-small cell lung cancer (NSCLC) 4
Stopping tyrosine kinase inhibitors a second or third time after unsuccesful treatment discontinuation in chronic myeloid leukemia Pending

2024-519472-69-00 CML-Patients in chronic phase having failed a prior att 4
The Surf trial Pending

2025-523898-42-00 Histologically confirmed solid malignancy (e.g., head a 10
Dose monitoring of commonly used cytostatic drugs for breast cancer Pending

2024-514818-12-00 Breast cancer female NOS 6
K-SAB trial Pending

2024-515250-25-00 Advanced KRASG12C-mutated non-small cell lung cancer su 3
Quality of life and neurocognitive functioning in diffuse low-grade glioma patients treated with Temozolomide: feasibility study - TEMOIN Pending

2024-516918-37-00 Diffuse low-grade gliomas 4
Time restricted Eating And Metformin (TEAM) in invasive breast cancer (IBC) or ductal carcinoma in situ (DCIS). A randomized, phase IIb, win… Pending

2024-518402-40-00 Luminal (ER+ve and/or PgR+ve >=1%) invasive breast canc 4
Phase 2, open-label, multicentre, single-arm study to evaluate the activity of the combination of EGFR inhibitors and c-MET inhibitors in pa… Pending

2024-518892-72-00 Head and neck cancer 4
First-in-Human Dose Study of IOA-244 in patients with advanced or metastatic cancers. Pending

2024-518404-44-00 Advanced solid tumours and metastatic cancers 1
Effect of perioperative intravenous infusion of lidocaine on the postoperative course and the immune response in patients undergoing surgery… Pending

2025-521808-22-01 Colon cancer 4
A phase 2, Multicenter Study of TILs Treatment in Germ Cell tumors: the ARES Study Pending

2025-522427-10-00 Germ Cell Tumors refractory to salvage chemotherapy 4
Molecularly Tailored Therapy versus Standard Care in Advanced Pancreatic Cancer Pending

2025-522431-34-00 Advanced pancreatic cancer 4
BEACON 2: A Multi-Arm, Multi-Stage Platform Trial For Relapsed Neuroblastoma Pending

2024-516115-24-00 High risk relapsed neuroblastoma (relapsed or progresse 9
Changes in the tumour microenvironment after intravenous or intradermal administration of anti-CTLA-4 in combination with anti-PD1 treatment… Pending

2024-516545-39-01 unresectable stage III – IV melanoma 9
A study to evaluate the efficacy and safety of belantamab mafodotin in combination with standard of care in participants aged 18 years and o… Pending

2025-523117-28-00 Relapsed or Refractory Multiple Myeloma 4
Feasibility clinical trial of the combination of AloCelyvir with chemotherapy and radiotherapy for the treatment of children and adolescents… Pending

2024-518417-25-00 Relapsed or refractory extracranial solid tumors in chi 3
Study of Volrustomig as Monotherapy or in Combination with Anti- cancer Agents in Participants with Advanced/Metastatic Solid Tumors Pending

2025-523947-36-00 Sub-study 5: Unresectable Pleural Mesothelioma (Volrust 4
The impact of Thromboprophylaxis on Progression Free Survival of Patients with Advanced Pancreatic Cancer. The Pancreatic Cancer & Tinzapari… Pending

2024-520043-17-00 Thromboprophylaxis in patients with advanced pancreatic 5
NEOAC Pending

2024-516126-54-00 ANAPLASTIC THYROID CANCER 4
Phase II Prospective Multicenter Study of High-Dose Treosulfan/Melphalan as Consolidation Treatment in Newly Diagnosed High-Risk and Very Hi… Pending

2024-518912-37-01 Ewing Sarcoma 4
Evaluation study of a treatement with Nivolumab and Ipilimumab or tKi according to molecular group in naïve metastatic Kidney cancer Pending

2024-520045-23-00 Kidney cancer 4
Efficacy and safety of cannabidiol to patients with advanced prostate cancer Pending

2024-513951-33-00 Prostate cancer 4
Bladder Preservation with Sacituzumab Govitecan + Zimberelimab for MuscleInvasive Bladder cancer in cisplatin-unfit and unwilling for cystec… Pending

2024-516943-14-01 Muscle-Invasive Bladder cancer 4
Durvalumab (MEDI4736) in combination with consolidative radiochemotherapy and ablative stereotactic radiotherapy in extensive stage SCLC Pending

2024-517937-41-00 extensive stage small cell lung cancer (SCLC) 4